Learn more information about PLUVICTO, available before chemotherapy for the treatment of PSMA+ mCRPC. See full Prescribing and Safety Info.

Learn how PLUVICTO, the first and only radioligand therapy (RLT) for PSMA+ mCRPC, works as a targeted treatment. See full Prescribing and Safety Info.

Learn about safety precautions & what to expect when taking PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) injection. See full Prescribing & Safety Info.

Here are some materials you can use to learn more about PSMA+ mCRPC and PLUVICTO. You can download, print, and revisit them at any stage in your or your loved one's treatment.

Find a list of answers to frequently asked questions about PSMA+ mCRPC and treatment with PLUVICTO. See full Prescribing and Safety Info.

View the response to treatment with PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) injection in two clinical studies. See full Prescribing & Safety Info.

Learn if PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) treatment could be next for your PSMA+ mCRPC. See full Prescribing and Safety Info.

Interested in receiving information about PLUVICTO? PLUVICTO® Pulse is a series of emails that helps you talk to your doctor about PLUVICTO.

Find information about the side effects of treatment with PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) injection. See full Prescribing & Safety Info.

Access the locator to find the nearest PLUVICTO® (Lutetium Lu 177 vipivotide tetraxetan) treatment center. See full Prescribing and Safety Information.